Updated November 25 at 3:25pm
49 results total, viewing 41 - 49
Voyager Therapeutics, a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system, has entered into a strategic collaboration with MassBiologics of the University of Massachusetts Medical School. more
Amgen Inc. won U.S. approval for its powerful cholesterol-lowering drug Repatha for certain patients, making it the second in a new class of treatments to come to market. more
Medtronic PLC will spend as much as $458 million to buy Twelve Inc., becoming the latest medical-device giant to buy an experimental product to replace the heart’s mitral valve without open-heart surgery. more
Medtronic PLC, the world’s biggest maker of heart-rhythm devices, reported first-quarter profit that topped analysts’ estimates on strong demand for its newest products to monitor the heart and repair damaged valves. more
A biomedical engineering professor at the University of Rhode Island has received a $6 million National Science Foundation grant for research to show how the nervous system functions in health and disease. more
Biotechnology giant Amgen Inc. posted third- quarter earnings that topped analysts’ estimates, driven by higher drug sales, and raised its forecast for the year. more
To Amgen Inc.'s Senior Manager for Manufacturing Jimmy Fleming, the task of ensuring that he and his team are producing a quality product is of the utmost importance – professionally and personally. Fleming's sister is one of the more … more
(Updated, 5:40 p.m.) Ximedica announced Tuesday it has purchased the San Francisco-based Bridge Design, providing the Rhode Island-based medical technology development company with a West Coast hub. more
(Updated, 4 p.m., Aug. 21) Some of the region’s most notable companies have been named in Providence Business News’ fourth Fastest-Growing & Innovative Companies awards program. more
« Prev | 1 | 2 | 3 | 4 | 5